Showing results (221-230 of 366) with videos related to
Sort By:
Pageof 37
The American Journal of Managed Care|July 19, 2022
Medicare Advantage coverage restrictions for the costliest physician-administered drugsKelly E Anderson, G Caleb Alexander, Carolyne Ma, et al.Health Affairs Scholar|July 28, 2025
Research and development investments for biologics independently developed by US biotechnology startups, 2017-2023Ilina C Odouard, So-Yeon Kang, Jessica Mo, et al.Annals of Internal Medicine|September 28, 2020
Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018James Heyward, Thomas J Moore, Jennifer Chen, et al.JAMA Internal Medicine|December 31, 2019
Evaluation of the Extended-Release/Long-Acting Opioid Prescribing Risk Evaluation and Mitigation Strategy Program by the US Food and Drug Administration: A ReviewJames Heyward, Lily Olson, Joshua M Sharfstein, et al.Journal of the American Geriatrics Society|February 1, 2019
Differences in National Diabetes Treatment Patterns and Trends between Older and Younger AdultsScott J Pilla, Jodi B Segal, G Caleb Alexander, et al.JAMA Internal Medicine|October 8, 2020
Assessment of Availability, Clinical Testing, and US Food and Drug Administration Review of Biosimilar Biologic ProductsThomas J Moore, Morgane C Mouslim, Jenna L Blunt, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 20, 2015
Effects of Televised Direct-to-Consumer Advertising for Varenicline on Prescription Dispensing in the United States, 2006-2009Yoonsang Kim, Rachel Kornfield, Yaru Shi, et al.Psychiatric Services (Washington, D.C.)|January 3, 2013
Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophreniaStacie B Dusetzina, Benjamin L Cook, Alisa B Busch, et al.JAMA|February 7, 2023
Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer AdvertisingMichael J DiStefano, Jenny M Markell, Caroline C Doherty, et al.JAMA Internal Medicine|March 29, 2021
Characteristics of Copayment Offsets for Prescription Drugs in the United StatesAditi P Sen, So-Yeon Kang, Emaan Rashidi, et al.Pageof 37